Cover Image

Editorial: Sepsis: basic, clinical and therapeutic approaches, volume II

Saved in:

Bibliographic Details
Main Authors:	Hong Zhou (Author), Yan Kang (Author), Daolin Tang (Author), Lefu Lan (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Sepsis: Basic, Clinical and Therapeutic Approaches
by: Yan Kang, et al.
Published: (2022)

Pharmacological Modulation of BET Family in Sepsis
by: Nian Wang, et al.
Published: (2021)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
by: Kyriaki Thermos, et al.
Published: (2022)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
by: Dan-Qian Chen, et al.
Published: (2022)

The emerging roles and therapeutic potential of B cells in sepsis
by: Chengyong Ma, et al.
Published: (2022)

Editorial: The pharmacotherapy of depression-searching for new mechanisms and drug interactions. Basic and clinical research, volume II
by: Katarzyna Stachowicz, et al.
Published: (2024)

Editorial: Medicinal Cannabis: evolution of therapeutic use, future approaches and other implications, volume II
by: Francesca Baratta, et al.
Published: (2023)

Editorial: Herbal medicines in managing stroke and neurodegenerative diseases-Is there evidence based on basic and clinical studies?, volume II
by: Huazheng Liang, et al.
Published: (2022)

Editorial: Recent advances in attempts to improve medication adherence - from basic research to clinical practice, volume II
by: Przemyslaw Kardas, et al.
Published: (2024)

Plumbagin Protects Mice from Lethal Sepsis by Modulating Immunometabolism Upstream of PKM2
by: Zhaoxia Zhang, et al.
Published: (2016)

The Art of War: Ferroptosis and Pancreatic Cancer
by: Jiao Liu, et al.
Published: (2021)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
by: Alexey V. Sokolov, et al.
Published: (2022)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
by: Chao-Yue Su, et al.
Published: (2023)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
by: Hendra Gunosewoyo, et al.
Published: (2023)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
by: Aiwei Yan, et al.
Published: (2023)

Editorial: "Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation"
by: Damiana Scuteri, et al.
Published: (2021)

Editorial: Novel approaches to the treatment of multidrug-resistant bacteria, Volume II
by: Priyia Pusparajah, et al.
Published: (2022)

Editorial: Natural products as an emerging therapeutic alternative for the treatment of anxiety and depression, Volume II
by: Ajmal Khan, et al.
Published: (2022)

Editorial: Apoptosis Induction/Suppression: A Feasible Approach for Natural Products to Treatment of Diseases, Volume II
by: Wei Peng, et al.
Published: (2022)

The Basic Writings of Josiah Royce, Volume II Logic, Loyalty, and Community
Published: (2005)

HDL in sepsis - risk factor and therapeutic approach
by: Emily E Morin, et al.
Published: (2015)

Editorial: Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design, Volume II
by: Leonardo L. G. Ferreira, et al.
Published: (2022)

Editorial: Therapeutic drug monitoring (TDM): a useful tool for pediatric pharmacology applied to routine clinical practice, Volume II
by: Raffaele Simeoli
Published: (2023)

Editorial: Eicosanoids in cancer, Volume II
by: Paola Patrignani, et al.
Published: (2023)

Editorial: Purinergic pharmacology, Volume II
by: Francisco Ciruela, et al.
Published: (2023)

Sepsis-induced AKI: From pathogenesis to therapeutic approaches
by: Fang-Fang He, et al.
Published: (2022)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
by: Cecilia Battistelli, et al.
Published: (2022)

Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
by: Momir Mikov, et al.
Published: (2023)

Editorial: Biorisk management, laboratory acquired infections and clinical containment, volume II
by: Kashif Ali, et al.
Published: (2024)

Editorial: Imaging technology in oncology pharmacological research, volume II
by: Qi Zeng, et al.
Published: (2022)

Editorial: Emerging pneumonia and acute lower respiratory infections in children, volume II
by: Hong-Ren Yu, et al.
Published: (2024)

Editorial: Workplace Health Promotion, volume II
by: Leah Okenwa Emegwa, et al.
Published: (2022)

Editorial: Pediatric endoscopy and sedation-volume II
by: Ron Shaoul, et al.
Published: (2024)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
by: Fanfan Zhou, et al.
Published: (2022)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs, Volume II
by: Ilaria Peluso, et al.
Published: (2022)

Maresins as novel anti-inflammatory actors and putative therapeutic targets in sepsis
by: Yan Sun, et al.
Published: (2024)

Editorial: Country profile of the epidemiology and clinical management of early childhood caries, volume II
by: Morenike Oluwatoyin Folayan, et al.
Published: (2023)

Editorial: Chlamydia trachomatis infection: Epidemiology, prevention, clinical, and basic science research
by: Changchang Li, et al.
Published: (2023)

Corrigendum: Editorial: Workplace health promotion, volume II
by: Leah Okenwa Emegwa, et al.
Published: (2023)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
by: Paula Gomes, et al.
Published: (2023)